BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29864514)

  • 1. Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals.
    Ito M; Shiba R; Watanabe M; Iwao Y; Itai S; Noguchi S
    Int J Pharm; 2018 Aug; 547(1-2):258-264. PubMed ID: 29864514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed Release of Clarithromycin from Tablets by Crystalline Phase Transition of Metastable Polymorph Form I.
    Fujiki S; Watanabe N; Iwao Y; Noguchi S; Mizoguchi M; Iwamura T; Itai S
    J Pharm Sci; 2015 Aug; 104(8):2641-4. PubMed ID: 26053058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative humidity-temperature transition boundaries for anhydrous β-caffeine and caffeine hydrate crystalline forms.
    Allan MC; Owens B; Mauer LJ
    J Food Sci; 2020 Jun; 85(6):1815-1826. PubMed ID: 32449950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RH-Temperature Stability Diagram of the Dihydrate, β-Anhydrate, and α-Anhydrate Forms of Crystalline Trehalose.
    Allan M; Chamberlain MC; Mauer LJ
    J Food Sci; 2019 Jun; 84(6):1465-1476. PubMed ID: 31042816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal.
    Watanabe M; Mizoguchi M; Aoki H; Iwao Y; Noguchi S; Itai S
    Int J Pharm; 2016 Oct; 512(1):108-117. PubMed ID: 27553780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process.
    Nozawa K; Iwao Y; Noguchi S; Itai S
    Int J Pharm; 2015 Nov; 495(1):204-217. PubMed ID: 26325306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RH-temperature stability diagram of α- and β-anhydrous and monohydrate lactose crystalline forms.
    Allan MC; Grush E; Mauer LJ
    Food Res Int; 2020 Jan; 127():108717. PubMed ID: 31882085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gel formation on the dissolution behavior of clarithromycin tablets.
    Inukai K; Takiyama K; Noguchi S; Iwao Y; Itai S
    Int J Pharm; 2017 Apr; 521(1-2):33-39. PubMed ID: 28196716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
    Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
    J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist.
    Takeuchi S; Kojima T; Hashimoto K; Saito B; Sumi H; Ishikawa T; Ikeda Y
    Chem Pharm Bull (Tokyo); 2015; 63(11):858-65. PubMed ID: 26521850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption.
    Pina MF; Pinto JF; Sousa JJ; Fábián L; Zhao M; Craig DQ
    Mol Pharm; 2012 Dec; 9(12):3515-25. PubMed ID: 23051151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free transport of water and CO2 in nonporous hydrophobic clarithromycin form II crystals.
    Tian J; Thallapally PK; Dalgarno SJ; Atwood JL
    J Am Chem Soc; 2009 Sep; 131(37):13216-7. PubMed ID: 19715295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of Novel Functional Formulations Based on Pharmaceutical Technologies].
    Itai S
    Yakugaku Zasshi; 2019; 139(3):419-435. PubMed ID: 30828022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the critical relative humidity for moisture-induced phase transitions.
    Burnett DJ; Thielmann F; Booth J
    Int J Pharm; 2004 Dec; 287(1-2):123-33. PubMed ID: 15541919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of clarithromycin.
    Sohn YT; Rhee JK; Im WB
    Arch Pharm Res; 2000 Aug; 23(4):381-4. PubMed ID: 10976587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Compaction Force on the Transition to Hydrate of Anhydrous Aripiprazole.
    Togo T; Taniguchi T; Nakata Y
    Chem Pharm Bull (Tokyo); 2018; 66(3):263-269. PubMed ID: 29491260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
    Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
    Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
    Amado AM; Nolasco MM; Ribeiro-Claro PJ
    J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic transformation of antibiotic clarithromycin under acidic condition.
    Noguchi S; Takiyama K; Fujiki S; Iwao Y; Miura K; Itai S
    J Pharm Sci; 2014 Feb; 103(2):580-6. PubMed ID: 24375227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.